Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 171INDUSTRY 72NIH 26NETWORK 19FED 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Recurrence 1Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

enzalutamide 4pembrolizumab 3Docetaxel 3apalutamide 2Testosterone 2Prednisone 2Cholecalciferol 2Celecoxib 2Androgen Antagonists 2Abiraterone Acetate 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2relugolix 1olaparib 1nilutamide 1histrelin 1gallium 68 PSMA-11 1capivasertib 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Yoga 1Triptorelin Pamoate 1Tablets 1Simvastatin 1Sildenafil Citrate 1Pluvicto 1Perioperative Care 1Pentoxifylline 1Methylprednisolone 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
FED × Prostatic Neoplasms × Docetaxel × Clear all
NCT00132301 2018-06-25

CAP

VA Office of Research and Development

Phase 3 Completed
298 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

NCT00870714 2009-03-27

IST 16167

Kansas City Veteran Affairs Medical Center

Phase NA Unknown
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT00215345 2005-09-22

A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

Department of Veterans Affairs, New Jersey

Phase 2 Unknown
66 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡